The effect of brain neurotrophic factor gene polymorphism on the effectiveness of therapeutic and rehabilitation measures in patients with psychostimulant dependence
Open Access
- 4 December 2021
- journal article
- research article
- Published by ECO-Vector LLC in Neurology Bulletin
- Vol. LIII (3) , 26-32
Abstract
Justification. Along with the rising consumption of psychostimulants, the number of patients with dependence on psychostimulants is increasing all over the world and in Russia in particular. At the same time, the number of patients with dependence on drug combinations is increasing, most of which are psychostimulants. Aim. The aim of the work is to develop a personalized approach to the therapy of patients with dependence on psychostimulants, taking into account the polymorphism of the neurotrophic factor gene of the brain. Material and methods. 305 patients with dependence on psychostimulants, men and women from 18 to 50 years old, were studied. Depending on the drug used and their combinations, as well as the presence of comorbid psychiatric pathology, all patients were divided into 6 groups. Research methods: molecular-genetic, clinical-psychopathological, catamnestic, statistical (parametric and nonparametric methods using Statistica 10.0 programs of STAT Soft Inc., USA). The effect of polymorphism of the neurotrophic factor gene of the brain on the effectiveness of therapeutic and rehabilitation measures in patients in different groups was evaluated. Results. It was found that patients who use only psychostimulants and psychostimulants with cannabinoids, having a homozygous (GG) genotype of the neurotrophic factor gene of the brain, are longer in the rehabilitation program and have the longest remissions. Conclusion. Polymorphism of the neurotrophic factor gene of the brain affects the effectiveness of therapeutic and rehabilitation measures in patients with dependence on psychostimulants.Keywords
This publication has 6 references indexed in Scilit:
- Towards a Biopsychosocial PsychiatryPsychiatry, 2019
- A PILOT STUDY OF GENETIC RISK MARKERS OF INTERNET ADDICTION: THE ROLE OF THE BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) AND DOPAMINE RECEPTOR D4 (DRD4) GENESВопросы наркологии, 2019
- Neurotrophic factors (BDNF and GDNF) and the serotonergic system of the brainBiochemistry (Moscow), 2017
- BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAPJournal of Psychopharmacology, 2012
- Brain neurotrophic factors. Neurochemical and narcological aspectsNeurochemical Journal, 2008
- Multivariate compactly supported biorthogonal spline waveletsAnnali di Matematica Pura ed Applicata (1923 -), 2002